KE

Kala Eswaran

Director Director DIN 03292773
DIN 03292773 First appointment Dec 2010 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2010
Shareholding value Locked Premium profile

About Kala Eswaran

Data last updated:

Kala Eswaran has 15 years in corporate governance. Formerly with 1 company, such as Om Medicaments Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03292773
Primary Designation Director
First Appointment 03 Dec 2010
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Om Medicaments Private Limited U51397MH2010PTC210562
Director03 Dec 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Om Medicaments Private Limited
Premium access

Shareholding and investment profile for Kala Eswaran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kala Eswaran

Kala Eswaran has 15 years in corporate governance. Formerly with 1 company, such as Om Medicaments Private Limited. Engaged in General Business. Contributes to corporate operations.

Kala Eswaran is associated with 0 companies as a director.

Kala Eswaran has expertise in General Business.

Kala Eswaran has 15 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available